Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study.
Wargny M, Potier L, Gourdy P, Pichelin M, Amadou C, Benhamou PY, Bonnet JB, Bordier L, Bourron O, Chaumeil C, Chevalier N, Darmon P, Delenne B, Demarsy D, Dumas M, Dupuy O, Flaus-Furmaniuk A, Gautier JF, Guedj AM, Jeandidier N, Larger E, Le Berre JP, Lungo M, Montanier N, Moulin P, Plat F, Rigalleau V, Robert R, Seret-Bégué D, Sérusclat P, Smati S, Thébaut JF, Tramunt B, Vatier C, Velayoudom FL, Vergès B, Winiszewski P, Zabulon A, Gourraud PA, Roussel R, Cariou B, Hadjadj S; CORONADO investigators. Diabetologia. 2021 Feb 17:1-17. doi: 10.1007/s00125-020-05351-w.
Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients – the COCAA-COLA cohort study.
Kevorkian JP, Lopes A, Sène D, Riveline JP, Vandiedonck C, Féron F, Nassarmadji K, Mouly S, Mauvais-Jarvis F, Gautier JF, Mégarbane B. J Infect. 2021 Feb 9:S0163-4453(21)00058-X. doi: 10.1016/j.jinf.2021.02.008.
Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity.
Flament H, Rouland M, Beaudoin L, Toubal A, Bertrand L, Lebourgeois S, Rousseau C, Soulard P, Gouda Z, Cagninacci L, Monteiro AC, Hurtado-Nedelec M, Luce S, Bailly K, Andrieu M, Saintpierre B, Letourneur F, Jouan Y, Si-Tahar M, Baranek T, Paget C, Boitard C, Vallet-Pichard A, Gautier JF, Ajzenberg N, Terrier B, Pène F, Ghosn J, Lescure X, Yazdanpanah Y, Visseaux B, Descamps D, Timsit JF, Monteiro RC, Lehuen A. Nat Immunol. 2021 Mar;22(3):322-335. doi: 10.1038/s41590-021-00870-z.
Use of dipeptidyl peptidase-4 inhibitors and prognosis of COVID-19 in hospitalized patients with type 2 diabetes: A propensity score analysis from the CORONADO study.
Roussel R, Darmon P, Pichelin M, Goronflot T, Abouleka Y, Ait Bachir L, Allix I, Ancelle D, Barraud S, Bordier L, Carlier A, Chevalier N, Coffin-Boutreux C, Cosson E, Dorange A, Dupuy O, Fontaine P, Fremy B, Galtier F, Germain N, Guedj AM, Larger E, Laugier-Robiolle S, Laviolle B, Ludwig L, Monier A, Montanier N, Moulin P, Moura I, Prevost G, Reznik Y, Sabbah N, Saulnier PJ, Serusclat P, Vatier C, Wargny M, Hadjadj S, Gourdy P, Cariou B; CORONADO investigators. Diabetes Obes Metab. 2021 Feb 2. doi: 10.1111/dom.14324.
Exposure to persistent organic pollutants and the risk of type 2 diabetes: a case-cohort study.
Magliano DJ, Rancière F, Slama R, Roussel R, Kiviranta H, Coumoul X, Balkau B, Botton J; D.E.S.I.R. Study Group. Diabetes Metab. 2021 Jan 27:101234. doi: 10.1016/j.diabet.2021.101234.
The corepressors GPS2 and SMRT control enhancer and silencer remodeling via eRNA transcription during inflammatory activation of macrophages.
Huang Z, Liang N, Goñi S, Damdimopoulos A, Wang C, Ballaire R, Jager J, Niskanen H, Han H, Jakobsson T, Bracken AP, Aouadi M, Venteclef N, Kaikkonen MU, Fan R, Treuter E. Mol Cell. 2021 Jan 21:S1097-2765(20)30961-8. doi: 10.1016/j.molcel.2020.12.040.
Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE study.
Bertrand C, Saulnier PJ, Potier L, Croyal M, Blanchard V, Gand E, Ragot S, Schneider F, Bocock O, Baillet-Blanco L, Velho G, Marre M, Roussel R, Rigalleau V, Hadjadj S, Mohammedi K; SURDIAGENE Study Group. Diabetologia. 2021 Mar;64(3):668-680. doi: 10.1007/s00125-020-05326-x. Epub 2021 Jan 6.
Association of diabetes and outcomes in patients with COVID-19: Propensity score-matched analyses from a French retrospective cohort.
Sutter W, Duceau B, Vignac M, Bonnet G, Carlier A, Roussel R, Trimaille A, Pommier T, Guilleminot P, Sagnard A, Pastier J, Weizman O, Giordano G, Cellier J, Geneste L, Panagides V, Marsou W, Deney A, Karsenty C, Attou S, Delmotte T, Ribeyrolles S, Chemaly P, Gautier A, Fauvel C, Chaumont C, Mika D, Pezel T, Cohen A, Potier L; Critical COVID-19 France Investigators. Diabetes Metab. 2020 Dec 31:101222. doi: 10.1016/j.diabet.2020.101222.
Regulation of glycolytic genes in human macrophages by oxysterols: a potential role for liver X receptors.
Ménégaut L, Jalil A, Pilot T, van Dongen K, Crespy V, Steinmetz E, Pais de Barros JP, Geissler A, Le Goff W, Venteclef N, Lagrost L, Gautier T, Thomas C, Masson D. Br J Pharmacol. 2020 Dec 29. doi: 10.1111/bph.15358.
Stay-at-Home Orders During the COVID-19 Pandemic, an Opportunity to Improve Glucose Control Through Behavioral Changes in Type 1 Diabetes.
Potier L, Hansel B, Larger E, Gautier JF, Carreira D, Assemien R, Lantieri O, Riveline JP, Roussel R. Diabetes Care. 2021 Mar;44(3):839-843. doi: 10.2337/dc20-2019.
Impact of BMI on prevalence of coronary atherosclerotic lesions in non-smoking premenopausal diabetic women: A monocentric study.
Salle L, Denis M, Feron F, Dillinger JG, Henry P, Gautier JF, Kevorkian JP. Diabetes Metab. 2020 Dec 22;47(4):101218. doi: 10.1016/j.diabet.2020.101218.
Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19.
Lalau JD, Al-Salameh A, Hadjadj S, Goronflot T, Wiernsperger N, Pichelin M, Allix I, Amadou C, Bourron O, Duriez T, Gautier JF, Dutour A, Gonfroy C, Gouet D, Joubert M, Julier I, Larger E, Marchand L, Marre M, Meyer L, Olivier F, Prevost G, Quiniou P, Raffaitin-Cardin C, Roussel R, Saulnier PJ, Seret-Begue D, Thivolet C, Vatier C, Desailloud R, Wargny M, Gourdy P, Cariou B; CORONADO investigators. Diabetes Metab. 2020 Dec 10;47(5):101216. doi: 10.1016/j.diabet.2020.101216.
Coronary Artery Calcification and Complications in Patients With COVID-19.
Dillinger JG, Benmessaoud FA, Pezel T, Voicu S, Sideris G, Chergui N, Hamzi L, Chauvin A, Leroy P, Gautier JF, Sène D, Henry P; COVID Research Group of Lariboisiere Hospital. JACC Cardiovasc Imaging. 2020 Nov;13(11):2468-2470. doi: 10.1016/j.jcmg.2020.07.004.
Plasma total adiponectin and changes in renal function in a cohort from the community: the prospective Data from an Epidemiological Study on the Insulin Resistance Syndrome study.
Fumeron F, El Boustany R, Bastard JP, Fellahi S, Balkau B, Marre M, Venteclef N, Velho G, Roussel R. Nephrol Dial Transplant. 2020 Nov 3:gfaa228. doi: 10.1093/ndt/gfaa228.
Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study.
Cariou B, Goronflot T, Rimbert A, Boullu S, Le May C, Moulin P, Pichelin M, Potier L, Smati S, Sultan A, Tramunt B, Wargny M, Gourdy P, Hadjadj S; CORONADO investigators. Diabetes Metab. 2020 Oct 19:101202. doi: 10.1016/j.diabet.2020.10.001.
Relationship Between Diabetic Retinopathy Stages and Risk of Major Lower-Extremity Arterial Disease in Patients With Type 2 Diabetes.
Foussard N, Saulnier PJ, Potier L, Ragot S, Schneider F, Gand E, Monlun M, Baillet-Blanco L, Velho G, Marre M, Roussel R, Rigalleau V, Mohammedi K, Hadjadj S; SURDIAGENE Study Group. Diabetes Care. 2020 Nov;43(11):2751-2759. doi: 10.2337/dc20-1085.
Relationship between obesity and severe COVID-19 outcomes in patients with type 2 diabetes: Results from the CORONADO study.
Smati S, Tramunt B, Wargny M, Caussy C, Gaborit B, Vatier C, Vergès B, Ancelle D, Amadou C, Bachir LA, Bourron O, Coffin-Boutreux C, Barraud S, Dorange A, Fremy B, Gautier JF, Germain N, Larger E, Laugier-Robiolle S, Meyer L, Monier A, Moura I, Potier L, Sabbah N, Seret-Bégué D, Winiszewski P, Pichelin M, Saulnier PJ, Hadjadj S, Cariou B, Gourdy P; CORONADO investigators. Diabetes Obes Metab. 2021 Feb;23(2):391-403. doi: 10.1111/dom.14228.
Pathogenic variants in actionable MODY genes are associated with type 2 diabetes.
Bonnefond A, Boissel M, Bolze A, Durand E, Toussaint B, Vaillant E, Gaget S, Graeve F, Dechaume A, Allegaert F, Guilcher DL, Yengo L, Dhennin V, Borys JM, Lu JT, Cirulli ET, Elhanan G, Roussel R, Balkau B, Marre M, Franc S, Charpentier G, Vaxillaire M, Canouil M, Washington NL, Grzymski JJ, Froguel P.Nat Metab. 2020 Oct;2(10):1126-1134. doi: 10.1038/s42255-020-00294-3.
Switching between GLP-1 receptor agonists in clinical practice: Expert consensus and practical guidance.
Jain AB, Ali A, Gorgojo Martínez JJ, Hramiak I, Kavia K, Madsbad S, Potier L, Prohaska BD, Strong JL, Vilsbøll T. Int J Clin Pract. 2021 Feb;75(2):e13731. doi: 10.1111/ijcp.13731.
Adipocyte Reprogramming by the Transcriptional Coregulator GPS2 Impacts Beta Cell Insulin Secretion.
Drareni K, Ballaire R, Alzaid F, Goncalves A, Chollet C, Barilla S, Nguewa JL, Dias K, Lemoine S, Riveline JP, Roussel R, Dalmas E, Velho G, Treuter E, Gautier JF, Venteclef N. Cell Rep. 2020 Sep 15;32(11):108141. doi: 10.1016/j.celrep.2020.108141.
Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study.
Kevorkian JP, Riveline JP, Vandiedonck C, Girard D, Galland J, Féron F, Gautier JF, Mégarbane B. J Infect. 2021 Jan;82(1):e22-e24. doi: 10.1016/j.jinf.2020.08.045.
Type 1 Diabetes in People Hospitalized for COVID-19: New Insights From the CORONADO Study.
Wargny M, Gourdy P, Ludwig L, Seret-Bégué D, Bourron O, Darmon P, Amadou C, Pichelin M, Potier L, Thivolet C, Gautier JF, Hadjadj S, Cariou B; CORONADO investigators. Diabetes Care. 2020 Nov;43(11):e174-e177. doi: 10.2337/dc20-1217.
Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID-19 in type 2 diabetes.
Alzaid F, Julla JB, Diedisheim M, Potier C, Potier L, Velho G, Gaborit B, Manivet P, Germain S, Vidal-Trecan T, Roussel R, Riveline JP, Dalmas E, Venteclef N, Gautier JF. EMBO Mol Med. 2020 Oct 7;12(10):e13038. doi: 10.15252/emmm.202013038.
Blood glucose levels and COVID-19. Reply to Sardu C, D’Onofrio N, Balestrieri ML et al [letter] and Lepper PM, Bals R, Jüni P et al [letter].
Cariou B, Hadjadj S, Wargny M, Pichelin M, Al-Salameh A, Allix I, Amadou C, Arnault G, Baudoux F, Bauduceau B, Borot S, Bourgeon-Ghittori M, Bourron O, Boutoille D, Cazenave-Roblot F, Chaumeil C, Cosson E, Coudol S, Darmon P, Disse E, Ducet-Boiffard A, Gaborit B, Joubert M, Kerlan V, Laviolle B, Marchand L, Meyer L, Potier L, Prevost G, Riveline JP, Robert R, Saulnier PJ, Sultan A, Thébaut JF, Thivolet C, Tramunt B, Vatier C, Roussel R, Gautier JF, Gourdy P; CORONADO investigators. Diabetologia. 2020 Nov;63(11):2491-2494. doi: 10.1007/s00125-020-05255-9.
Loss of G protein pathway suppressor 2 in human adipocytes triggers lipid remodeling by upregulating ATP binding cassette subfamily G member 1.
Barilla S, Liang N, Mileti E, Ballaire R, Lhomme M, Ponnaiah M, Lemoine S, Soprani A, Gautier JF, Amri EZ, Le Goff W, Venteclef N, Treuter E. Mol Metab. 2020 Dec;42:101066. doi: 10.1016/j.molmet.2020.101066.